The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.20
Bid: 44.10
Ask: 45.90
Change: -0.50 (-1.10%)
Spread: 1.80 (4.082%)
Open: 43.00
High: 43.20
Low: 43.00
Prev. Close: 45.50
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Joint Venture with AquaChile

29 May 2019 07:00

RNS Number : 3914A
Benchmark Holdings PLC
29 May 2019
 

 

29 May 2019

 

Benchmark Holdings plc

 

("Benchmark" or the "Company")

 

Update on Joint Venture with Empresas AquaChile S.A. (AquaChile)

 

Opportunity for Benchmark to take control of a salmon breeding operation

and pursue an independent strategy in Chile

 

Benchmark, the aquaculture health, nutrition and genetics business, today announces an update on its joint venture (JV) with AquaChile, its Chilean breeding and genetics partner. In January 2019 Agrosuper completed the acquisition of AquaChile; as a consequence, Benchmark has the opportunity to take control of a salmon breeding operation in Chile currently owned by the JV, allowing it to pursue an independent strategy. The Company is in discussions with AquaChile regarding the dissolution of the joint venture.

 

The discussions envisage a return of the Company's original equity investment in the JV, together with Benchmark's IP rights, the genetic stock and biomass, and resources sufficient to operate the 50m egg facility. The Company expects to reinvest the returned funds in the wholly owned business in the coming years to allow the Company to enhance biosecurity and achieve full scale production at the bio-secure, land based facility. The Company expects that the proposed strategy will deliver returns in line with those set out when entering the JV.

 

Benchmark Genetics, under the joint venture with AquaChile, has been successful in accelerating its entry into the Chilean market as a local player with the launch of Benchmark Genetics Chile in October 2018, and the successful establishment of its genetics programme locally, creating a strong platform for growth. Chile is the world's second largest salmon producing country, and an important market in Benchmark's long term strategy.

 

Malcolm Pye, Benchmark Chief Executive, commented:

 

"We are pleased to have the opportunity to fully own the world class salmon breeding facility currently owned by the JV and to reinvest the funds to move towards full scale production and commercialisation. We look forward to strengthening both our relationships and cooperation with existing and new partners in Chile.

 

"Whilst this marks a change to Benchmark's approach to the market, it is a positive step towards fulfilling our key objective of accelerating our establishment of a strong local presence in this important market, in line with our strategy."

 

 

- ENDS -

 

Enquiries

 

For further information, please contact:

 

Benchmark Holdings plc

Tel: 020 3915 1236

Malcolm Pye, CEO

 

Mark Plampin, CFO

 

Ivonne Cantu, Investor Relations

 

 

 

 

 

Numis (Broker and NOMAD)

Tel: 020 7260 1000

James Black, Freddie Barnfield, Freddie Naylor-Leyland

 

 

 

 

 

MHP Communications

Tel: 020 3128 8742 / 07551 170 451

Katie Hunt / Reg Hoare / Alistair de Kare-Silver benchmark@mphc.com

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCZMGZKGRVGLZZ
Date   Source Headline
21st Jun 20214:41 pmRNSSecond Price Monitoring Extn
21st Jun 20214:36 pmRNSPrice Monitoring Extension
2nd Jun 20214:41 pmRNSSecond Price Monitoring Extn
2nd Jun 20214:35 pmRNSPrice Monitoring Extension
28th May 20217:00 amRNSTotal Voting Rights
25th May 20217:00 amRNSDirector Dealings
18th May 20217:00 amRNSSecond Quarter and Interim results
30th Apr 20217:00 amRNSTotal Voting Rights
19th Apr 20217:00 amRNSNotice of Q2 and Interim Results
16th Apr 202111:00 amRNSBMK08+CleanTreat Update
31st Mar 20213:41 pmRNSDirector Dealings
31st Mar 20217:00 amRNSTotal Voting Rights
30th Mar 20217:00 amRNSListing of existing senior secured NOK bond
26th Mar 20218:24 amRNSBMK08+CleanTreat Update
19th Mar 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
26th Feb 202110:52 amRNSTotal Voting Rights
22nd Feb 20217:00 amRNSQ1 Results
9th Feb 202112:43 pmRNSResult of AGM
9th Feb 20217:00 amRNSNotice of Q1 Results
29th Jan 20217:00 amRNSTotal Voting Rights
13th Jan 20217:00 amRNSIssue of Equity
8th Jan 20211:13 pmRNSReplacement: DIRECTOR SHARE OPTIONS
8th Jan 20219:57 amRNSDIRECTOR SHARE OPTIONS
6th Jan 20213:45 pmRNSDirector Dealings
31st Dec 20207:00 amRNSTotal Voting Rights
11th Dec 20205:32 pmRNSPosting of Annual Report and Notice of AGM
2nd Dec 20202:09 pmRNSDirector Dealings
1st Dec 20204:02 pmRNSAnnual Financial Report
1st Dec 202011:30 amRNSDirector Dealings
1st Dec 202010:30 amRNSDirector Dealings
1st Dec 202010:21 amRNSPCA Dealing
30th Nov 20207:00 amRNSTotal Voting Rights
27th Nov 20207:00 amRNSQ4 Results
27th Nov 20207:00 amRNSFull Year Results
18th Nov 20207:00 amRNSDirectorate Change
4th Nov 20207:00 amRNSInvestor Presentation for Retail Investors
30th Oct 20207:00 amRNSTotal Voting Rights
27th Oct 20207:00 amRNSNotice of Results
13th Oct 20202:29 pmRNSHolding(s) in Company
12th Oct 20202:50 pmRNSHolding(s) in Company
30th Sep 20207:00 amRNSTotal Voting Rights
29th Sep 20207:00 amRNSHolding(s) in Company
21st Sep 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
11th Sep 20205:58 pmRNSHolding(s) in Company
10th Sep 20209:15 amRNSPositive Opinion from the EMA on BMK08
4th Sep 20207:00 amRNSDirector/PDMR Shareholding
28th Aug 20207:00 amRNSTotal Voting Rights
28th Aug 20207:00 amRNSQ3 Results
21st Aug 20207:00 amRNSNotice of Q3 Results
31st Jul 202011:17 amRNSCompletion of sale of vaccine facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.